EUVIMEDEUVIMED entdecken
Fallbericht

The use of a tumor necrosis factor inhibitor—adalimumab—in the management of arthritis in an adolescent with HIV : A case report

Reima Bakry iD, Nada Bokhary iD, Esraa Sendi iD, Malak Alshehri iD, Lama Sindi iD, Hend Alkwai iD

International Journal of Rheumatic Diseases · 2024

DOI: 10.1111/1756-185x.14827 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Reima Bakry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, East Jeddah Hospital, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: HIV Infections, Antirheumatic Agents, Arthritis, Rheumatoid. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human immunodeficiency virus (HIV) infection is associated with a myriad of musculoskeletal manifestations. Inflammatory arthritis has been described in association with HIV in both adults and children. Biologic disease‐modifying anti‐rheumatic drugs, particularly tumor necrosis factor inhibitors (TNFi), have been reported to manage inflammatory arthritis in adults with HIV when conventional therapy fails to control arthritis. In this report, we describe the management of arthritis and enthesitis in a 12‐year‐old adolescent male with HIV using the TNFi adalimumab. At the time of presentation, the patient was on highly active antiretroviral therapy for 1 year. His viral load was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAntirheumatic AgentsArthritis, RheumatoidAdultMaleAdolescentHumansChildAdalimumabTumor Necrosis Factor InhibitorsEtanerceptTumor Necrosis Factor-alphaTreatment OutcomeInfliximab

Stichwörter der Autor:innen

HIV-1adalimumabarthritistumor necrosis factor inhibitor

Substanzen

AdalimumabTumor Necrosis Factor InhibitorsEtanerceptTumor Necrosis Factor-alphaAntirheumatic AgentsInfliximab

Autor:innen und Institutionen

  • Department of Pediatrics, East Jeddah Hospital, Jeddah, Saudi Arabia.
  • College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Pediatrics, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.

ORCID-Profile: Reima Bakry, Nada Bokhary, Esraa Sendi, Malak Alshehri, Lama Sindi, Hend Alkwai

Zitieren

APA

Bakry, R., Bokhary, N., Sendi, E., Alshehri, M., Sindi, L., & Alkwai, H. (2024). The use of a tumor necrosis factor inhibitor—adalimumab—in the management of arthritis in an adolescent with HIV : A case report. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.14827

Vancouver

Bakry R, Bokhary N, Sendi E, Alshehri M, Sindi L, Alkwai H. The use of a tumor necrosis factor inhibitor—adalimumab—in the management of arthritis in an adolescent with HIV : A case report. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.14827

BibTeX
@article{Bakry2024,
  author = {Bakry, Reima and Bokhary, Nada and Sendi, Esraa and Alshehri, Malak and Sindi, Lama and Alkwai, Hend},
  title = {The use of a tumor necrosis factor inhibitor—adalimumab—in the management of arthritis in an adolescent with HIV : A case report},
  journal = {International Journal of Rheumatic Diseases},
  year = {2024},
  doi = {10.1111/1756-185x.14827}
}
Kostenlos starten →